Heptares Therapeutics
E108401
UNEXPLORED
Heptares Therapeutics is a biopharmaceutical company specializing in the discovery and development of medicines targeting G protein-coupled receptors (GPCRs) using its proprietary structure-based drug design technologies.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.